BACKGROUND/ OBJECTIVES: Notifying partners of HIV-infected persons and referring them for testing and treatment is an effective method of disease control and identification of undiagnosed STD and/or HIV. To improve partner elicitation interviews, disease intervention specialists (DIS) were placed in 3 HIV clinics during 2008 and 2009. METHODS: We reviewed the Arizona state STD surveillance database for 2007 to identify the providers (outside of the public STD clinics) reporting the highest number of syphilis cases. DIS were placed in the clinics for half a day per week (2 clinics) or on an on-call basis (1 clinic) to deliver penicillin and interview patients. We calculated changes in the number of patients interviewed, days elapsed from specimen collection to treatment (time to treatment), days elapsed from specimen collection to initial DIS contact (time to interview), and number of reported and locatable partners from these 3 clinics before and after the clinic placement of DIS. RESULTS: Before the placement of clinic-based DIS, 219 syphilis cases were diagnosed at the 3 clinics (January 2006 through January 2008). After DIS placement, 115 syphilis cases were diagnosed (February 2008 through September 2009) for a total of 334 cases in this analysis. A greater percent of patients completed a partner elicitation interview during the period of DIS placement (94% after vs. 81% before, P = 0.001). There were increases in the average number of locatable partners (1.1 after vs. 0.6 before, P = 0.004) and an increase in the average number of partners exposed and brought to treatment (CDC Disposition A) or infected and brought to treatment (CDC Disposition C) (0.6 after vs. 0.3 before, P = 0.02), and the time to interview decreased (18 days before vs. 9 days after, P = 0.02). CONCLUSIONS/IMPLICATIONS: Placing DIS within community HIV clinics improved partner services. STD and/or HIV programs should consider this method to improve partner notification.
BACKGROUND/ OBJECTIVES: Notifying partners of HIV-infectedpersons and referring them for testing and treatment is an effective method of disease control and identification of undiagnosed STD and/or HIV. To improve partner elicitation interviews, disease intervention specialists (DIS) were placed in 3 HIV clinics during 2008 and 2009. METHODS: We reviewed the Arizona state STD surveillance database for 2007 to identify the providers (outside of the public STD clinics) reporting the highest number of syphilis cases. DIS were placed in the clinics for half a day per week (2 clinics) or on an on-call basis (1 clinic) to deliver penicillin and interview patients. We calculated changes in the number of patients interviewed, days elapsed from specimen collection to treatment (time to treatment), days elapsed from specimen collection to initial DIS contact (time to interview), and number of reported and locatable partners from these 3 clinics before and after the clinic placement of DIS. RESULTS: Before the placement of clinic-based DIS, 219 syphilis cases were diagnosed at the 3 clinics (January 2006 through January 2008). After DIS placement, 115 syphilis cases were diagnosed (February 2008 through September 2009) for a total of 334 cases in this analysis. A greater percent of patients completed a partner elicitation interview during the period of DIS placement (94% after vs. 81% before, P = 0.001). There were increases in the average number of locatable partners (1.1 after vs. 0.6 before, P = 0.004) and an increase in the average number of partners exposed and brought to treatment (CDC Disposition A) or infected and brought to treatment (CDC Disposition C) (0.6 after vs. 0.3 before, P = 0.02), and the time to interview decreased (18 days before vs. 9 days after, P = 0.02). CONCLUSIONS/IMPLICATIONS: Placing DIS within community HIV clinics improved partner services. STD and/or HIV programs should consider this method to improve partner notification.
Authors: Roxanne P Kerani; H Hunter Handsfield; Mark S Stenger; Taraneh Shafii; Ellen Zick; Devon Brewer; Matthew R Golden Journal: Sex Transm Dis Date: 2007-03 Impact factor: 2.830
Authors: Janet S St Lawrence; Daniel E Montaño; Danuta Kasprzyk; William R Phillips; Keira Armstrong; Jami S Leichliter Journal: Am J Public Health Date: 2002-11 Impact factor: 9.308
Authors: Kate Buchacz; Pragna Patel; Melanie Taylor; Peter R Kerndt; Robert H Byers; Scott D Holmberg; Jeffrey D Klausner Journal: AIDS Date: 2004-10-21 Impact factor: 4.177
Authors: Matthew R Golden; Sharon G Hopkins; Martina Morris; King K Holmes; H Hunter Handsfield Journal: J Acquir Immune Defic Syndr Date: 2003-02-01 Impact factor: 3.731
Authors: Matthew R Golden; Matthew Hogben; H Hunter Handsfield; Janet S St Lawrence; John J Potterat; King K Holmes Journal: Sex Transm Dis Date: 2003-06 Impact factor: 2.830
Authors: Chi-Chi N Udeagu; Dipal Shah; Colin W Shepard; Angelica Bocour; Rodolfo Guiterrez; Elizabeth M Begier Journal: Public Health Rep Date: 2012 Jan-Feb Impact factor: 2.792
Authors: Brooke E Hoots; Pia D M MacDonald; Lisa B Hightow-Weidman; Peter A Leone; William C Miller Journal: Sex Transm Dis Date: 2012-01 Impact factor: 2.830
Authors: Christine L Heumann; David A Katz; Julia C Dombrowski; Amy B Bennett; Lisa E Manhart; Matthew R Golden Journal: Sex Transm Dis Date: 2017-04 Impact factor: 2.830
Authors: Sally C Stephens; Charles K Fann; Frank V Strona; Wendy Wolf; Stephanie E Cohen; Susan S Philip; Kyle T Bernstein Journal: Sex Transm Dis Date: 2014-05 Impact factor: 2.830
Authors: Brooke E Hoots; Felicia M T Lewis; Greta Anschuetz; Julia A Schillinger; Susan Blank; Tammy Foskey; Jeffrey A Stover; Thomas A Peterman Journal: Sex Transm Dis Date: 2014-06 Impact factor: 2.830
Authors: William A Mase; Andrew R Hansen; Stacy W Smallwood; Gulzar Shah; Angela H Peden; Ted Mulherin; Kaye Bender Journal: Public Health Rep Date: 2018-10-10 Impact factor: 2.792
Authors: Melanie M Taylor; Julia A Schillinger; Bruce W Furness; Toye Brewer; Daniel R Newman; Preeti Pathela; Julia Skinner; Sarah Braunstein; Colin Shepard; Tashrik Ahmed; Angelique Griffin; Susan Blank; Thomas A Peterman Journal: J Acquir Immune Defic Syndr Date: 2013-09-01 Impact factor: 3.731